Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | HCRTR1 | O43613 | 10/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 9/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | FPR1 | P21462 | 1/20 | 0.33 |
| ▸ | FPR2 | P25090 | 1/20 | 0.33 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.32 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.32 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | FLT4 | P35916 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17618570 | 0.91 | ALOX15 (0.38) | CYP2C19PIK3CAMAPTALOX15TSHR | |
| SCHEMBL16754358 | 0.90 | PIK3CA (0.47) | CYP2C19PIK3CAMAPTALOX15TSHR | |
| SCHEMBL16754326 | 0.88 | MAPT (0.35) | CYP2C19PIK3CAMAPTALOX15TSHR | |
| SCHEMBL17778872 | 0.88 | MAPT (0.35) | CYP2C19PIK3CAMAPTALOX15TSHR | |
| SCHEMBL19669051 | 0.86 | MAPT (0.38) | CYP2C19PIK3CAMAPTALOX15TSHR | |
| SCHEMBL16754497 | 0.86 | AKT1 (0.37) | CYP2C19PIK3CAHCRTR1HCRTR2MAPT | |
| SCHEMBL16754348 | 0.86 | CYP2C19 (0.37) | CYP2C19PIK3CAHCRTR1HCRTR2MAPT | |
| SCHEMBL16249951 | 0.84 | ABL1 (0.38) | CYP2C19PIK3CAMAPTALOX15TSHR | |
| SCHEMBL17618909 | 0.84 | ALOX15 (0.44) | CYP2C19MAPTALOX15TSHRCASP1 | |
| SCHEMBL16754405 | 0.83 | NR3C2 (0.38) | CYP2C19PIK3CAALOX15TSHRCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150152108-A1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | GLAXOSMITHKLINE LLC | 2015-06-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152108-A1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | SIRT1, SIRT3, SIRT2 | CYP2C19 2647/4885PIK3CA 3691/4885HCRTR1 2303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.